Literature DB >> 26070620

Brachial Artery Access.

Kyungmouk Steve Lee1, Thomas A Sos2.   

Abstract

Low brachial artery access is a safe alternative approach for the interventionalist when the femoral artery approach is not feasible or desirable. One important advantage of upper extremity access is the favorable route of entry from above into the caudally oriented visceral arteries. Although the risk of complications is low for experienced operators, meticulous attention to technique and knowledge of local anatomy are imperative to safely use brachial artery access. Adequate anticoagulation with heparin and use of lowest-profile devices may minimize complications. Following these procedures, patients must be carefully evaluated immediately and trained to self-monitor for up to 2 weeks for signs and symptoms of bleeding and nerve compression. This article describes the indications, procedural steps, expected outcomes, and tips on overcoming technical challenges of brachial artery access.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  brachial artery access; upper extremity access

Mesh:

Year:  2015        PMID: 26070620     DOI: 10.1053/j.tvir.2015.04.006

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  3 in total

Review 1.  Ultrasound guidance for arterial (other than femoral) catheterisation in adults.

Authors:  Ronald Lg Flumignan; Virginia Fm Trevisani; Renato D Lopes; Jose Cc Baptista-Silva; Carolina Dq Flumignan; Luis Cu Nakano
Journal:  Cochrane Database Syst Rev       Date:  2021-10-12

2.  MDCT angiography of emergent, non-traumatic, upper extremity vascular lesions.

Authors:  Sameer Ahmed; Megan H Lee; Hannah Ahn; Elliot K Fishman
Journal:  Br J Radiol       Date:  2020-08-12       Impact factor: 3.039

3.  Hemostasis After Brachial Artery Access With the MynxGrip Device: A Case Report.

Authors:  Arturo Giordano; Stefano Messina; Gennaro Maresca; Giuseppe Biondi-Zoccai
Journal:  Clin Med Insights Cardiol       Date:  2018-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.